Home Procurement NewsBristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss

Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss

April 25, 2024•

Bristol Myers Squibb said the charges primarily reflect its acquisition of Karuna Therapeutics and collaboration agreement with SystImmune.

Was this article helpful?
YesNo

Last modified: April 25, 2024

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Close Search Window